Publications

Detailed Information

Developing a biological age assessment equation using principal component analysis and clinical biomarkers of aging in Korean men

DC Field Value Language
dc.contributor.authorPark, JinHo-
dc.contributor.authorCho, BeLong-
dc.contributor.authorLee, CheolMin-
dc.contributor.authorKwon, HyukTae-
dc.date.accessioned2012-05-22T01:37:01Z-
dc.date.available2012-05-22T01:37:01Z-
dc.date.issued2009-08-
dc.identifier.citationARCHIVES OF GERONTOLOGY AND GERIATRICS; Vol.49 1; 7-12ko_KR
dc.identifier.issn0167-4943-
dc.identifier.urihttps://hdl.handle.net/10371/76197-
dc.description.abstractThe purpose of the present study is to find clinically useful candidate biomarkers of aging,and using these to develop an equation measuring biological age(BA) in Korean men, then to validate the clinical usefulness of it. Among 4288 men who received medical health examinations, we selected 1588 men who met the normality criteria of each variable. We assumed that chronological ages (CA) of healthy persons represent the BA of them. Variables showing significant correlations with CA were selected. Redundant variables were excluded. We selected 11 variables: VO(2)max, percent body fat (%BF), waist circumference (WC), forced expiratory volume in 1s (FEV1), systolic blood pressure (SBP), low density cholesterol (LDLCH), blood urea nitrogen (BUN), serum albumin (SA), erythrocyte sedimentation rate(ESR) hearing threshold (HT), and glycosylated hemoglobin (HBA1C). These 11 variables were then submitted into principal component analysis (PCA) and standardized BA scores were obtained. Using them and T-scale idea, the following equation to assess BA was developed: BA= -28.7+0.83(%BF)+0.48(WC)+0.13(SBP)- 0.27(VO(2)max)+ 0.19(HT)-3.1(FEV1)+0.32(BUN)+0.06(LDLCH)-3.0(SA)+0.34(ESR)+ 4.6(HBA1C). We compared the BA of 3122 men by their fasting glucose and age level. The BA of the higher glucose level group was significantly higher than that of others at all CA levels. the selected 11 biomarkers encompassed known clinically important factors of adult diseases and functional disabilities. This BA assessment equation can be used in the general Korean male Population and it proved to be clinically useful. (C) 2008 Elsevier Ireland Ltd. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER IRELAND LTDko_KR
dc.subjectBiological ageko_KR
dc.subjectBiomarkers of agingko_KR
dc.subjectChronological ageko_KR
dc.subjectPrincipal component analysisko_KR
dc.titleDeveloping a biological age assessment equation using principal component analysis and clinical biomarkers of aging in Korean menko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박진호-
dc.contributor.AlternativeAuthor조비롱-
dc.contributor.AlternativeAuthor이철민-
dc.contributor.AlternativeAuthor권혁태-
dc.identifier.doi10.1016/j.archger.2008.04.003-
dc.citation.journaltitleARCHIVES OF GERONTOLOGY AND GERIATRICS-
dc.description.citedreferenceNAKAMURA E, 1994, EXP GERONTOL, V29, P151-
dc.description.citedreferenceCOOK NR, 1991, AM J EPIDEMIOL, V133, P784-
dc.description.citedreferenceGATES GA, 1990, EAR HEARING, V11, P247-
dc.description.citedreferenceLIGTHART GJ, 1990, MECH AGEING DEV, V55, P89-
dc.description.citedreferenceFOZARD JL, 1990, J GERONTOL, V45, P116-
dc.description.citedreferenceHOCHSCHILD R, 1990, J GERONTOL, V45, P187-
dc.description.citedreferenceHOCHSCHILD R, 1989, EXP GERONTOL, V24, P289-
dc.description.citedreferenceNAKAMURA E, 1988, MECH AGEING DEV, V46, P1-
dc.description.citedreferenceFLEG JL, 1988, J APPL PHYSIOL, V65, P1147-
dc.description.citedreferenceBURT VL, 1995, HYPERTENSION, V25, P305-
dc.description.citedreferenceMcClearn GE, 1997, EXP GERONTOL, V32, P87-
dc.description.citedreferenceNakamura E, 1998, EXP GERONTOL, V33, P421-
dc.description.citedreferenceKRUTKO VN, 2001, FIZIOL CHELOVEKA, V27, P88-
dc.description.citedreferenceKRUTKO VN, 2002, FIZIOL CHELOVEKA, V28, P95-
dc.description.citedreferenceERLICHMAN J, 2002, OBES REV, V3, P257-
dc.description.citedreferenceUENO LM, 2003, J PHYSL ANTHR APPL H, V22, P37-
dc.description.citedreferenceAndresdottir MB, 2003, AM J EPIDEMIOL, V158, P844, DOI 10.1093/aje/kwg222-
dc.description.citedreferenceShaper AG, 2004, J CLIN EPIDEMIOL, V57, P195, DOI 10.1016/j.jclinepi.2003.07.001-
dc.description.citedreferenceStone NJ, 2005, AM J CARDIOL, V96, p53E, DOI 10.1016/j.amjcard.2005.06.006-
dc.description.citedreference*ADA, 2007, DIABETES CARE S, V1, pS4-
dc.description.citedreferenceZhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886-
dc.description.citedreferenceBAKER GT, 1988, EXP GERONTOL, V23, P223-
dc.description.citedreferenceDUBINA TL, 1984, EXP GERONTOL, V19, P133-
dc.description.citedreferenceVOITENKO VP, 1983, EXP AGING RES, V9, P239-
dc.description.citedreferenceDUBINA TL, 1983, EXP GERONTOL, V18, P5-
dc.description.citedreferenceINGRAM DK, 1983, EXP AGING RES, V9, P225-
dc.description.citedreferenceHOFECKER G, 1980, MECH AGEING DEV, V14, P345-
dc.description.citedreferenceLUDWIG FC, 1980, EXP AGING RES, V6, P497-
dc.description.citedreferenceWEBSTER IW, 1976, J GERONTOL, V31, P546-
dc.description.citedreferenceFURUKAWA T, 1975, J GERONTOL, V30, P422-
dc.description.citedreferenceHEIKKINE.E, 1974, GERONTOLOGY, V20, P33-
dc.description.citedreferenceFRIEDEWA.WT, 1972, CLIN CHEM, V18, P499-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share